Cite
HARVARD Citation
Sun, L. et al. (n.d.). 466P Gefitinib retreatment beyond progression in advanced NSCLC patients with sensitive EGFR mutations. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sun, L. et al. (n.d.). 466P Gefitinib retreatment beyond progression in advanced NSCLC patients with sensitive EGFR mutations. Annals of oncology. p. . [Online].